Details for New Drug Application (NDA): 207580
✉ Email this page to a colleague
The generic ingredient in AUROVELA FE 1.5/30 is ethinyl estradiol; norethindrone acetate. There are twenty-six drug master file entries for this compound. Twenty-seven suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone acetate profile page.
Summary for 207580
Tradename: | AUROVELA FE 1.5/30 |
Applicant: | Aurobindo Pharma |
Ingredient: | ethinyl estradiol; norethindrone acetate |
Patents: | 0 |
Suppliers and Packaging for NDA: 207580
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
AUROVELA FE 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 207580 | ANDA | Aurobindo Pharma Limited | 65862-941 | 65862-941-58 | 5 POUCH in 1 CARTON (65862-941-58) / 1 BLISTER PACK in 1 POUCH (65862-941-87) / 1 KIT in 1 BLISTER PACK |
AUROVELA FE 1.5/30 | ethinyl estradiol; norethindrone acetate | TABLET;ORAL-28 | 207580 | ANDA | Aurobindo Pharma Limited | 65862-941 | 65862-941-88 | 3 POUCH in 1 CARTON (65862-941-88) / 1 BLISTER PACK in 1 POUCH / 1 KIT in 1 BLISTER PACK |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL-28 | Strength | 0.03MG;1.5MG | ||||
Approval Date: | Jun 15, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription